![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 7, 4540-4547, February 17, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B
Is Required for Tumor Necrosis Factor Inhibition of Peroxisome Proliferator-activated Receptor
Function*




1
From the
Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808 and
Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Inhibition of peroxisome proliferator-activated receptor
(PPAR
) function by TNF-
contributes to glucose and fatty acid metabolic disorders in inflammation and cancer, although the molecular mechanism is not fully understood. In this study, we demonstrate that nuclear translocation of HDAC3 is regulated by TNF-
, and this event is required for inhibition of transcriptional activity of PPAR
by TNF-
. HDAC3 is associated with I
B
in the cytoplasm. After I
B
degradation in response to TNF-
, HDAC3 is subject to nuclear translocation, leading to an increase in HDAC3 activity in the nucleus. This event leads to subcellular redistribution of HDAC3. Knock-out of I
B
, but not p65 or p50, leads to disappearance of HDAC3 in the cytoplasm, which is associated with HDAC3 enrichment in the nucleus. These data suggest that inhibition of PPAR
by TNF-
is not associated with a reduction in the DNA binding activity of PPAR
. Rather, these results suggest that I
B
-dependent nuclear translocation of HDAC3 is responsible for PPAR
inhibition by TNF-
.
Received for publication, July 18, 2005 , and in revised form, December 16, 2005.
* This study is supported by National Institutes of Health Grant DK068036 and an American Diabetes Association research award (to J. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Pennington Biomedical Research Center, 6400 Perkins Rd., Baton Rouge, LA 70808. Tel.: 225-763-3163; Fax: 225-763-2525; E-mail: yej{at}pbrc.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Pang, Z. Gao, J. Yin, J. Zhang, W. Jia, and J. Ye Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E313 - E322. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ye, Z. Gao, J. Yin, and Q. He Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1118 - E1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yan, Z. Gao, G. Yu, Q. He, J. Weng, and J. Ye Nuclear Corepressor Is Required for Inhibition of Phosphoenolpyruvate Carboxykinase Expression by Tumor Necrosis Factor-{alpha} Mol. Endocrinol., July 1, 2007; 21(7): 1630 - 1641. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Escaffit, O. Vaute, M. Chevillard-Briet, B. Segui, Y. Takami, T. Nakayama, and D. Trouche Cleavage and Cytoplasmic Relocalization of Histone Deacetylase 3 Are Important for Apoptosis Progression Mol. Cell. Biol., January 15, 2007; 27(2): 554 - 567. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |